APO Research
Talk to an analyst

APO RESEARCH · REPORT

Phosphodiesterase (PDE) inhibitors

Compare research editions
View pricing & licenses

Selected research

Industry Research

Phosphodiesterase (PDE) inhibitors Industry Research Report 2026

22 December 2025116 pages

Choose your research edition.

Industry ResearchPhosphodiesterase (PDE) inhibitors Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Phosphodiesterase (PDE) inhibitors Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Phosphodiesterase (PDE) inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Phosphodiesterase (PDE) inhibitors Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Phosphodiesterase (PDE) inhibitors Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Phosphodiesterase (PDE) inhibitors market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Phosphodiesterase (PDE) inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Phosphodiesterase (PDE) inhibitors is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Phosphodiesterase (PDE) inhibitors is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Phosphodiesterase (PDE) inhibitors include Eli Lilly and Co., Pfizer Inc., GlaxoSmithKline Plc, Bayer AG and Vivus Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Phosphodiesterase (PDE) inhibitors market in terms of revenue (US$ million) and, where applicable, sales volume (L), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/L) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Phosphodiesterase (PDE) inhibitors Market by Company

Eli Lilly and Co.

Pfizer Inc.

GlaxoSmithKline Plc

Bayer AG

Vivus Inc.

Phosphodiesterase (PDE) inhibitors Segment by Type

PDE10 selective inhibitors

PDE1 Selective Inhibitors

PDE2 Selective Inhibitors

PDE3 Selective Inhibitors

PDE4 selective inhibitors

PDE5 selective inhibitors

PDE7 selective inhibitors

Phosphodiesterase (PDE) inhibitors Segment by Application

Oral

Topical

Other

Phosphodiesterase (PDE) inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phosphodiesterase (PDE) inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Phosphodiesterase (PDE) inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phosphodiesterase (PDE) inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Phosphodiesterase (PDE) inhibitors manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Phosphodiesterase (PDE) inhibitors by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Phosphodiesterase (PDE) inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Phosphodiesterase (PDE) inhibitors Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Phosphodiesterase (PDE) inhibitors Sales (L) of Manufacturers (2021-2026) Table 7. Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Manufacturers (2021-2026) Table 8. Global Phosphodiesterase (PDE) inhibitors Revenue of Manufacturers (2021-2026) Table 9. Global Phosphodiesterase (PDE) inhibitors Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Phosphodiesterase (PDE) inhibitors Average Price (US$/L) of Manufacturers (2021-2026) Table 11. Global Phosphodiesterase (PDE) inhibitors Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Phosphodiesterase (PDE) inhibitors, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Phosphodiesterase (PDE) inhibitors, Product Type & Application Table 14. Global Phosphodiesterase (PDE) inhibitors Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Phosphodiesterase (PDE) inhibitors by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Eli Lilly and Co. Company Information Table 19. Eli Lilly and Co. Business Overview Table 20. Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 21. Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Product Portfolio Table 22. Eli Lilly and Co. Recent Developments Table 23. Pfizer Inc. Company Information Table 24. Pfizer Inc. Business Overview Table 25. Pfizer Inc. Phosphodiesterase (PDE) inhibitors Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 26. Pfizer Inc. Phosphodiesterase (PDE) inhibitors Product Portfolio Table 27. Pfizer Inc. Recent Developments Table 28. GlaxoSmithKline Plc Company Information Table 29. GlaxoSmithKline Plc Business Overview Table 30. GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 31. GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Product Portfolio Table 32. GlaxoSmithKline Plc Recent Developments Table 33. Bayer AG Company Information Table 34. Bayer AG Business Overview Table 35. Bayer AG Phosphodiesterase (PDE) inhibitors Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 36. Bayer AG Phosphodiesterase (PDE) inhibitors Product Portfolio Table 37. Bayer AG Recent Developments Table 38. Vivus Inc. Company Information Table 39. Vivus Inc. Business Overview Table 40. Vivus Inc. Phosphodiesterase (PDE) inhibitors Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 41. Vivus Inc. Phosphodiesterase (PDE) inhibitors Product Portfolio Table 42. Vivus Inc. Recent Developments Table 43. Global Phosphodiesterase (PDE) inhibitors Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Phosphodiesterase (PDE) inhibitors Sales by Region (2021-2026) & (L) Table 45. Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Region (2021-2026) Table 46. Global Phosphodiesterase (PDE) inhibitors Sales by Region (2027-2032) & (L) Table 47. Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Region (2027-2032) Table 48. Global Phosphodiesterase (PDE) inhibitors Revenue by Region (2021-2026) & (US$ Million) Table 49. Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Region (2021-2026) Table 50. Global Phosphodiesterase (PDE) inhibitors Revenue by Region (2027-2032) & (US$ Million) Table 51. Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Region (2027-2032) Table 52. North America Phosphodiesterase (PDE) inhibitors Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 53. North America Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2026) & (L) Table 54. North America Phosphodiesterase (PDE) inhibitors Sales by Country (2027-2032) & (L) Table 55. North America Phosphodiesterase (PDE) inhibitors Revenue by Country (2021-2026) & (US$ Million) Table 56. North America Phosphodiesterase (PDE) inhibitors Revenue by Country (2027-2032) & (US$ Million) Table 57. Europe Phosphodiesterase (PDE) inhibitors Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Europe Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2026) & (L) Table 59. Europe Phosphodiesterase (PDE) inhibitors Sales by Country (2027-2032) & (L) Table 60. Europe Phosphodiesterase (PDE) inhibitors Revenue by Country (2021-2026) & (US$ Million) Table 61. Europe Phosphodiesterase (PDE) inhibitors Revenue by Country (2027-2032) & (US$ Million) Table 62. Asia Pacific Phosphodiesterase (PDE) inhibitors Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Asia Pacific Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2026) & (L) Table 64. Asia Pacific Phosphodiesterase (PDE) inhibitors Sales by Country (2027-2032) & (L) Table 65. Asia Pacific Phosphodiesterase (PDE) inhibitors Revenue by Country (2021-2026) & (US$ Million) Table 66. Asia Pacific Phosphodiesterase (PDE) inhibitors Revenue by Country (2027-2032) & (US$ Million) Table 67. South America Phosphodiesterase (PDE) inhibitors Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 68. South America Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2026) & (L) Table 69. South America Phosphodiesterase (PDE) inhibitors Sales by Country (2027-2032) & (L) Table 70. South America Phosphodiesterase (PDE) inhibitors Revenue by Country (2021-2026) & (US$ Million) Table 71. South America Phosphodiesterase (PDE) inhibitors Revenue by Country (2027-2032) & (US$ Million) Table 72. Middle East and Africa Phosphodiesterase (PDE) inhibitors Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2026) & (L) Table 74. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Country (2027-2032) & (L) Table 75. Middle East and Africa Phosphodiesterase (PDE) inhibitors Revenue by Country (2021-2026) & (US$ Million) Table 76. Middle East and Africa Phosphodiesterase (PDE) inhibitors Revenue by Country (2027-2032) & (US$ Million) Table 77. Global Phosphodiesterase (PDE) inhibitors Sales by Type (2021-2026) & (L) Table 78. Global Phosphodiesterase (PDE) inhibitors Sales by Type (2027-2032) & (L) Table 79. Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2021-2026) Table 80. Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2027-2032) Table 81. Global Phosphodiesterase (PDE) inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 82. Global Phosphodiesterase (PDE) inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 83. Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Type (2021-2026) Table 84. Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Type (2027-2032) Table 85. Global Phosphodiesterase (PDE) inhibitors Price by Type (2021-2026) & (US$/L) Table 86. Global Phosphodiesterase (PDE) inhibitors Price by Type (2027-2032) & (US$/L) Table 87. Global Phosphodiesterase (PDE) inhibitors Sales by Application (2021-2026) & (L) Table 88. Global Phosphodiesterase (PDE) inhibitors Sales by Application (2027-2032) & (L) Table 89. Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2021-2026) Table 90. Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2027-2032) Table 91. Global Phosphodiesterase (PDE) inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 92. Global Phosphodiesterase (PDE) inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 93. Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Application (2021-2026) Table 94. Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Application (2027-2032) Table 95. Global Phosphodiesterase (PDE) inhibitors Price by Application (2021-2026) & (US$/L) Table 96. Global Phosphodiesterase (PDE) inhibitors Price by Application (2027-2032) & (US$/L) Table 97. Key Raw Materials Table 98. Raw Materials Key Suppliers Table 99. Phosphodiesterase (PDE) inhibitors Distributors List Table 100. Phosphodiesterase (PDE) inhibitors Customers List Table 101. Phosphodiesterase (PDE) inhibitors Industry Trends Table 102. Phosphodiesterase (PDE) inhibitors Industry Drivers Table 103. Phosphodiesterase (PDE) inhibitors Industry Restraints Table 104. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Phosphodiesterase (PDE) inhibitors Product Image Figure 5. Global Phosphodiesterase (PDE) inhibitors Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Phosphodiesterase (PDE) inhibitors Market Size (2021-2032) & (US$ Million) Figure 7. Global Phosphodiesterase (PDE) inhibitors Sales (2021-2032) & (L) Figure 8. Global Phosphodiesterase (PDE) inhibitors Average Price (US$/L) & (2021-2032) Figure 9. PDE10 selective inhibitors Product Image Figure 10. PDE1 Selective Inhibitors Product Image Figure 11. PDE2 Selective Inhibitors Product Image Figure 12. PDE3 Selective Inhibitors Product Image Figure 13. PDE4 selective inhibitors Product Image Figure 14. PDE5 selective inhibitors Product Image Figure 15. PDE7 selective inhibitors Product Image Figure 16. Oral Product Image Figure 17. Topical Product Image Figure 18. Other Product Image Figure 19. Global Phosphodiesterase (PDE) inhibitors Revenue Share by Manufacturers in 2025 Figure 20. Global Manufacturers of Phosphodiesterase (PDE) inhibitors, Manufacturing Sites & Headquarters Figure 21. Global Top 5 and 10 Phosphodiesterase (PDE) inhibitors Players Market Share by Revenue in 2025 Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Phosphodiesterase (PDE) inhibitors Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 24. Global Phosphodiesterase (PDE) inhibitors Sales by Region in 2025 Figure 25. Global Phosphodiesterase (PDE) inhibitors Revenue by Region in 2025 Figure 26. North America Phosphodiesterase (PDE) inhibitors Market Size by Country in 2025 Figure 27. North America Phosphodiesterase (PDE) inhibitors Sales Market Share by Country (2021-2032) Figure 28. North America Phosphodiesterase (PDE) inhibitors Revenue Market Share by Country (2021-2032) Figure 29. United States Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Canada Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Mexico Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Europe Phosphodiesterase (PDE) inhibitors Market Size by Country in 2025 Figure 33. Europe Phosphodiesterase (PDE) inhibitors Sales Market Share by Country (2021-2032) Figure 34. Europe Phosphodiesterase (PDE) inhibitors Revenue Market Share by Country (2021-2032) Figure 35. Germany Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. France Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. U.K. Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Italy Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Russia Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Spain Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Netherlands Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Switzerland Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Sweden Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Poland Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Asia Pacific Phosphodiesterase (PDE) inhibitors Market Size by Country in 2025 Figure 46. Asia Pacific Phosphodiesterase (PDE) inhibitors Sales Market Share by Country (2021-2032) Figure 47. Asia Pacific Phosphodiesterase (PDE) inhibitors Revenue Market Share by Country (2021-2032) Figure 48. China Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Japan Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South Korea Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. India Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Australia Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Taiwan Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Southeast Asia Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Southeast Asia Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. South America Phosphodiesterase (PDE) inhibitors Market Size by Country in 2025 Figure 57. South America Phosphodiesterase (PDE) inhibitors Sales Market Share by Country (2021-2032) Figure 58. South America Phosphodiesterase (PDE) inhibitors Revenue Market Share by Country (2021-2032) Figure 59. Brazil Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Argentina Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Chile Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Colombia Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Middle East and Africa Phosphodiesterase (PDE) inhibitors Market Size by Country in 2025 Figure 64. Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales Market Share by Country (2021-2032) Figure 65. Middle East and Africa Phosphodiesterase (PDE) inhibitors Revenue Market Share by Country (2021-2032) Figure 66. Egypt Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. South Africa Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Israel Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Türkiye Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. GCC Countries Phosphodiesterase (PDE) inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 71. Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2021-2032) Figure 72. Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Type (2021-2032) Figure 73. Global Phosphodiesterase (PDE) inhibitors Price (US$/L) by Type (2021-2032) Figure 74. Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2021-2032) Figure 75. Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Application (2021-2032) Figure 76. Global Phosphodiesterase (PDE) inhibitors Price (US$/L) by Application (2021-2032) Figure 77. Phosphodiesterase (PDE) inhibitors Value Chain Figure 78. Phosphodiesterase (PDE) inhibitors Production Mode & Process Figure 79. Direct Comparison with Distribution Share Figure 80. Distributors Profiles Figure 81. Phosphodiesterase (PDE) inhibitors Industry Opportunities and Challenges

Scope & coverage.

Types
  • PDE10 selective inhibitors
  • PDE1 Selective Inhibitors
  • PDE2 Selective Inhibitors
  • PDE3 Selective Inhibitors
  • PDE4 selective inhibitors
  • PDE5 selective inhibitors
  • PDE7 selective inhibitors
Applications
  • Oral
  • Topical
  • Other
Companies covered
  • Eli Lilly and Co.
  • Pfizer Inc.
  • GlaxoSmithKline Plc
  • Bayer AG
  • Vivus Inc.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Phosphodiesterase (PDE) inhibitors Market Size (2021-2032)
  4. 2.2.2 Global Phosphodiesterase (PDE) inhibitors Sales (2021-2032)
  5. 2.2.3 Global Phosphodiesterase (PDE) inhibitors Market Average Price (2021-2032)
  6. 2.3 Phosphodiesterase (PDE) inhibitors by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 PDE10 selective inhibitors
  9. 2.3.3 PDE1 Selective Inhibitors
  10. 2.3.4 PDE2 Selective Inhibitors
  11. 2.3.5 PDE3 Selective Inhibitors
  12. 2.3.6 PDE4 selective inhibitors
  13. 2.3.7 PDE5 selective inhibitors
  14. 2.3.8 PDE7 selective inhibitors
  15. 2.4 Phosphodiesterase (PDE) inhibitors by Application
  16. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  17. 2.4.2 Oral
  18. 2.4.3 Topical
  19. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Phosphodiesterase (PDE) inhibitors Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Phosphodiesterase (PDE) inhibitors Sales (L) of Manufacturers (2021-2026)
  3. 3.3 Global Phosphodiesterase (PDE) inhibitors Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Phosphodiesterase (PDE) inhibitors Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Phosphodiesterase (PDE) inhibitors Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Phosphodiesterase (PDE) inhibitors, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Phosphodiesterase (PDE) inhibitors, Product Type & Application
  8. 3.8 Global Manufacturers of Phosphodiesterase (PDE) inhibitors, Established Date
  9. 3.9 Global Phosphodiesterase (PDE) inhibitors Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Eli Lilly and Co.
  2. 4.1.1 Eli Lilly and Co. Company Information
  3. 4.1.2 Eli Lilly and Co. Business Overview
  4. 4.1.3 Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Eli Lilly and Co. Phosphodiesterase (PDE) inhibitors Product Portfolio
  6. 4.1.5 Eli Lilly and Co. Recent Developments
  7. 4.2 Pfizer Inc.
  8. 4.2.1 Pfizer Inc. Company Information
  9. 4.2.2 Pfizer Inc. Business Overview
  10. 4.2.3 Pfizer Inc. Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Pfizer Inc. Phosphodiesterase (PDE) inhibitors Product Portfolio
  12. 4.2.5 Pfizer Inc. Recent Developments
  13. 4.3 GlaxoSmithKline Plc
  14. 4.3.1 GlaxoSmithKline Plc Company Information
  15. 4.3.2 GlaxoSmithKline Plc Business Overview
  16. 4.3.3 GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Product Portfolio
  18. 4.3.5 GlaxoSmithKline Plc Recent Developments
  19. 4.4 Bayer AG
  20. 4.4.1 Bayer AG Company Information
  21. 4.4.2 Bayer AG Business Overview
  22. 4.4.3 Bayer AG Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Bayer AG Phosphodiesterase (PDE) inhibitors Product Portfolio
  24. 4.4.5 Bayer AG Recent Developments
  25. 4.5 Vivus Inc.
  26. 4.5.1 Vivus Inc. Company Information
  27. 4.5.2 Vivus Inc. Business Overview
  28. 4.5.3 Vivus Inc. Phosphodiesterase (PDE) inhibitors Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Vivus Inc. Phosphodiesterase (PDE) inhibitors Product Portfolio
  30. 4.5.5 Vivus Inc. Recent Developments
5 Global Phosphodiesterase (PDE) inhibitors Market Scenario by Region
  1. 5.1 Global Phosphodiesterase (PDE) inhibitors Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Phosphodiesterase (PDE) inhibitors Sales by Region: 2021-2032
  3. 5.2.1 Global Phosphodiesterase (PDE) inhibitors Sales by Region: 2021-2026
  4. 5.2.2 Global Phosphodiesterase (PDE) inhibitors Sales by Region: 2027-2032
  5. 5.3 Global Phosphodiesterase (PDE) inhibitors Revenue by Region: 2021-2032
  6. 5.3.1 Global Phosphodiesterase (PDE) inhibitors Revenue by Region: 2021-2026
  7. 5.3.2 Global Phosphodiesterase (PDE) inhibitors Revenue by Region: 2027-2032
  8. 5.4 North America Phosphodiesterase (PDE) inhibitors Market Facts & Figures by Country
  9. 5.4.1 North America Phosphodiesterase (PDE) inhibitors Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2032)
  11. 5.4.3 North America Phosphodiesterase (PDE) inhibitors Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Phosphodiesterase (PDE) inhibitors Market Facts & Figures by Country
  16. 5.5.1 Europe Phosphodiesterase (PDE) inhibitors Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2032)
  18. 5.5.3 Europe Phosphodiesterase (PDE) inhibitors Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Phosphodiesterase (PDE) inhibitors Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Phosphodiesterase (PDE) inhibitors Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Phosphodiesterase (PDE) inhibitors Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Phosphodiesterase (PDE) inhibitors Market Facts & Figures by Country
  41. 5.7.1 South America Phosphodiesterase (PDE) inhibitors Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2032)
  43. 5.7.3 South America Phosphodiesterase (PDE) inhibitors Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Phosphodiesterase (PDE) inhibitors Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Phosphodiesterase (PDE) inhibitors Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Phosphodiesterase (PDE) inhibitors Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Phosphodiesterase (PDE) inhibitors Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Phosphodiesterase (PDE) inhibitors Sales by Type (2021-2032)
  2. 6.1.1 Global Phosphodiesterase (PDE) inhibitors Sales by Type (2021-2032) & (L)
  3. 6.1.2 Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Type (2021-2032)
  4. 6.2 Global Phosphodiesterase (PDE) inhibitors Revenue by Type (2021-2032)
  5. 6.2.1 Global Phosphodiesterase (PDE) inhibitors Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Phosphodiesterase (PDE) inhibitors Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Phosphodiesterase (PDE) inhibitors Sales by Application (2021-2032)
  2. 7.1.1 Global Phosphodiesterase (PDE) inhibitors Sales by Application (2021-2032) & (L)
  3. 7.1.2 Global Phosphodiesterase (PDE) inhibitors Sales Market Share by Application (2021-2032)
  4. 7.2 Global Phosphodiesterase (PDE) inhibitors Revenue by Application (2021-2032)
  5. 7.2.1 Global Phosphodiesterase (PDE) inhibitors Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Phosphodiesterase (PDE) inhibitors Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Phosphodiesterase (PDE) inhibitors Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Phosphodiesterase (PDE) inhibitors Value Chain Analysis
  2. 8.1.1 Phosphodiesterase (PDE) inhibitors Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Phosphodiesterase (PDE) inhibitors Production Mode & Process
  5. 8.2 Phosphodiesterase (PDE) inhibitors Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Phosphodiesterase (PDE) inhibitors Distributors
  8. 8.2.3 Phosphodiesterase (PDE) inhibitors Customers
9 Global Phosphodiesterase (PDE) inhibitors Analyzing Market Dynamics
  1. 9.1 Phosphodiesterase (PDE) inhibitors Industry Trends
  2. 9.2 Phosphodiesterase (PDE) inhibitors Industry Drivers
  3. 9.3 Phosphodiesterase (PDE) inhibitors Industry Opportunities and Challenges
  4. 9.4 Phosphodiesterase (PDE) inhibitors Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst